Increased carotid thickness in subjects with recently-diagnosed diabetes from rural cameroon

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Napoli, Nicola ^a,b   Zardi, Enrico ^a   Strollo, Rocky ^a   Arigliani, Michele ^a   Daverio, Andrea ^a   Olearo, Flaminia ^a   Tosi, Daniele ^a   Dicuonzo, Giordano ^a   Scarpa, Filomena ^a   Pedone, Claudio ^a   Tegue Simo, Hervé Hilaire ^c   Mottini, Giovanni ^a   Pozzilli, Paolo ^a,d  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Ministry of Health District of Baham   (Cameroon)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERY COMPLIANCE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; CAMEROON; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; MALE; RURAL AREA; TRIACYLGLYCEROL BLOOD LEVEL; YOUNG MODULUS;

CAMEROON; CAROTID ARTERIES; CASE-CONTROL STUDIES; DIABETES MELLITUS; HUMANS; RURAL POPULATION; TUNICA INTIMA;

EID: 84865173752     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041316     Document Type: Article

References (44)

1. Shaw JE, Sicree RA, Zimmet PZ, ((2010)) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:: 4--14.
2. Hossain P, Kawar B, El Nahas M, ((2007)) Obesity and diabetes in the developing world-a growing challenge. N Engl J Med 356:: 213--215.
3. Mbanya JC, Kengne AP, Assah F, ((2006)) Diabetes care in Africa. Lancet 368:: 1628--1629.
4. Mbanya JC, Ngogang J, Salah JN, Minkoulou E, Balkau B, ((1997)) Prevalence of NIDDM and impaired glucose tolerance in a rural and an urban population in Cameroon. Diabetologia 40:: 824--829.
5. Cooper RS, Rotimi CN, Kaufman JS, Muna WF, Mensah GA, ((1998)) Hypertension treatment and control in sub-Saharan Africa: the epidemiological basis for policy. BMJ 316:: 614--617.
6. Kengne AP, Amoah AG, Mbanya JC, ((2005)) Cardiovascular complications of diabetes mellitus in sub-Saharan Africa. Circulation 112:: 3592--3601.
7. Reddy KS, Yusuf S, ((1998)) Emerging epidemic of cardiovascular disease in developing countries. Circulation 97:: 596--601.
8. Centers for Disease Control and Prevention ((2002)) Tropical diabetic hand syndrome-Dar es Salaam, Tanzania, 1998-2002. MMWR Morb Mortal Wkly Rep 51:: 969--970.
9. Nambuya AP, Otim MA, Whitehead H, Mulvany D, Kennedy R, et al. ((1996)) The presentation of newly-diagnosed diabetic patients in Uganda. QJM 89:: 705--711.
10. Mbanya JC, Sobngwi E, ((2003)) Diabetes in Africa. Diabetes microvascular and macrovascular disease in Africa. J Cardiovasc Risk 10:: 97--102.
11. Mayosi B, ((2007)) A statement of intent on the formation of the NCRP on cardiovascular and metabolic disease: a new initiative to fight heart disease, stroke, diabetes and obesity in South Africa. Cardiovasc J S Afr 18:: 4--6.
12. Napoli N, Mottini G, Arigliani M, Creta A, Giua R, et al. ((2010)) Unexpectedly high rates of obesity and dysglycemia among villagers in Cameroon. Diabetes Metab Res Rev 26:: 10--12.
13. Napoli N, Thompson J, Civitelli R, Armamento-Villareal RC, ((2007)) Effects of dietary calcium compared with calcium supplements on estrogen metabolism and bone mineral density. Am J Clin Nutr 85:: 1428--1433.
14. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, et al. ((1998)) The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 128:: 262--269.
15. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, et al. ((1999)) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:: 14--22.
16. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, et al. ((2007)) 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28:: 1462--1536.
17. Touboul PJ, Vicaut E, Labreuche J, Belliard JP, Cohen S, et al. ((2005)) Design, baseline characteristics and carotid intima-media thickness reproducibility in the PARC study. Cerebrovasc Dis 19:: 57--63.
18. O'Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE, ((2002)) Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 15:: 426--444.
19. Laurent S, Brunel P, Lacolley P, Billaud E, Pannier B, et al. ((1988)) Flow-dependent vasodilation of the brachial artery in essential hypertension: preliminary report. J Hypertens Suppl 6:: S182--184.
20. Levitt NS, ((2008)) Diabetes in Africa: epidemiology, management and healthcare challenges. Heart 94:: 1376--1382.
21. Tsivgoulis G, Vemmos K, Papamichael C, Spengos K, Manios E, et al. ((2006)) Common carotid artery intima-media thickness and the risk of stroke recurrence. Stroke 37:: 1913--1916.
22. Shinoda-Tagawa T, Yamasaki Y, Yoshida S, Kajimoto Y, Tsujino T, et al. ((2002)) A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes. Diabetologia 45:: 188--194.
23. Bernard S, Serusclat A, Targe F, Charriere S, Roth O, et al. ((2005)) Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects. Diabetes Care 28:: 1158--1162.
24. Yamasaki Y, Kodama M, Nishizawa H, Sakamoto K, Matsuhisa M, et al. ((2000)) Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. Diabetes Care 23:: 1310--1315.
25. Shah AS, Dolan LM, Kimball TR, Gao Z, Khoury PR, et al. ((2009)) Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. J Clin Endocrinol Metab 94:: 3740--3745.
26. Liu YP, Zhan WW, Zhang YF, Chen YH, Lin YY, et al. ((2007)) Carotid intima-media thickness and stiffness in relation to type 2 diabetes in Chinese. Endocrine 31:: 289--293.
27. Wagenknecht LE, Zaccaro D, Espeland MA, Karter AJ, O'Leary DH, et al. ((2003)) Diabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol 23:: 1035--1041.
28. Wagenknecht LE, D'Agostino RB Jr, Haffner SM, Savage PJ, Rewers M, ((1998)) Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study. Diabetes Care 21:: 1812--1818.
29. International Diabetes Federation (2009) Diabetes Atlas 4th ed.: IDF (International Diabetes Federation).
30. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, et al. ((2009)) Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 32:: 287--294.
31. Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, et al. ((2011)) Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 365:: 213--221.
32. Distiller LA, Joffe BI, Melville V, Welman T, Distiller GB, ((2006)) Carotid artery intima-media complex thickening in patients with relatively long-surviving type 1 diabetes mellitus. J Diabetes Complications 20:: 280--284.
33. Distiller LA, Joffe BI, Brown V, Distiller GB, ((2010)) The effect of features of the metabolic syndrome on atherosclerotic risk in relatively long-surviving patients with type 1 diabetes. Metab Syndr Relat Disord 8:: 539--543.
34. Faeh D, William J, Yerly P, Paccaud F, Bovet P, ((2007)) Diabetes and pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity. Cardiovasc Diabetol 6:: 32.
35. Faeh D, William J, Tappy L, Ravussin E, Bovet P, ((2007)) Prevalence, awareness and control of diabetes in the Seychelles and relationship with excess body weight. BMC Public Health 7:: 163.
36. Stolar M, ((2010)) Glycemic control and complications in type 2 diabetes mellitus. Am J Med 123:: S3--11.
37. Yokoyama H, Katakami N, Yamasaki Y, ((2006)) Recent advances of intervention to inhibit progression of carotid intima-media thickness in patients with type 2 diabetes mellitus. Stroke 37:: 2420--2427.
38. Mazzone T, Meyer PM, Feinstein SB, Davidson MH, Kondos GT, et al. ((2006)) Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial. JAMA 296:: 2572--2581.
39. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:: 837--853.
40. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA, ((2008)) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:: 1577--1589.
41. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, et al. ((2009)) Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 32:: 187--192.
42. Fezeu L, Fointama E, Ngufor G, Mbeh G, Mbanya JC, ((2010)) Diabetes awareness in general population in Cameroon. Diabetes Res Clin Pract 90:: 312--318.
43. Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST, ((2010)) Diabetes in sub-Saharan Africa. Lancet 375:: 2254--2266.
44. International Diabetes Federation (1998) Access to insulin: a report on the IDF insulin task force on insulin, 1994-1997. Brussels:IDF. IDF (International Diabetes Federation).